# Evaluation of the Prevention and Treatment Effects of Chinese Medicine on High Altitude Illness

> **NCT01682551** · PHASE2 · UNKNOWN · sponsor: **China Medical University Hospital** · enrollment: 240 (estimated)

## Conditions studied

- Acute Mountain Sickness (AMS)

## Interventions

- **DRUG:** Chinese Medicine
- **DRUG:** Acetalozamide

## Key facts

- **NCT ID:** NCT01682551
- **Lead sponsor:** China Medical University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2012-09
- **Primary completion:** 2012-09
- **Final completion:** 2012-09
- **Target enrollment:** 240 (ESTIMATED)
- **Last updated:** 2012-09-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01682551

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01682551, "Evaluation of the Prevention and Treatment Effects of Chinese Medicine on High Altitude Illness". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01682551. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*